Company intelligence / Profile preview

IVREA Pharmaceuticals

Parsippany, New Jersey, USA

Ownership: Private
Development stage: Other

Overview

Ivrea Pharmaceuticals was a clinical-stage biopharmaceutical company focused on developing innovative topical therapies for dermatology. The company specialized in the proprietary formulation of established active pharmaceutical ingredients to improve efficacy and safety in treating skin diseases. Its lead development program featured a topical version of minocycline, a tetracycline antibiotic, aimed at treating inflammatory conditions like acne and rosacea. Founded by former executives of CollaGenex Pharmaceuticals, Ivrea leveraged deep expertise in the dermatology market. The company was backed by venture capital, notably HealthCare Ventures. In 2014, Ivrea was acquired by LEO Pharma, which sought to integrate Ivrea's topical minocycline technology into its global dermatology portfolio.

Therapeutic areas: Dermatology
Modalities: Small molecule
Industry: Biotech

Drug pipeline

2 assets

IVR-102

Preclinical

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on IVREA Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IVREA Pharmaceuticals.

Explore the full profile